Psychische Störungen bei Frauen: Verlauf und Besonderheiten im Zusammenhang mit den reproduktiven Phasen

Julia Martini; Susanne Knappe; Susan Garthus-Niegel; Jana Hoyer

doi:10.1055/s-0042-122585

Frauenheilkunde up2date, Table of Contents

Frauenheilkunde up2date 2017; 11(03): 267-285
DOI: 10.1055/s-0042-122585

Interdisziplinäre Themen

Georg Thieme Verlag KG Stuttgart · New York

Psychische Störungen bei Frauen: Verlauf und Besonderheiten im Zusammenhang mit den reproduktiven Phasen

Julia Martini

,

Susanne Knappe

,

Susan Garthus-Niegel

,

Jana Hoyer

Abstract

All articles of this category

Zahlreiche Studien zeigen bei Männern und Frauen in verschiedenen Altersgruppen unterschiedliche Prävalenzraten für psychische Störungen. Dieser Beitrag beschreibt den Verlauf psychischer Störungen bei Frauen unter Berücksichtigung der hormonellen und neuroendokrinen Besonderheiten im Zusammenhang mit dem Menstruationszyklus, der Schwangerschaft und Postpartalzeit sowie der Perimenopause.

Full Text

References

Literatur
1 Jacobi F, Höfler M, Strehle J. et al. Twelve-months prevalence of mental disorders in the German Health Interview and Examination Survey for Adults – Mental Health Module (DEGS1-MH): A methodological addendum and correction. Int J Methods Psychiatric Res 2015; 24: 305-313
2 Altemus M, Sarvaiya N, Epperson N. Sex differences in anxiety and depression clinical perspectives. Front Neuroendocrinol 2014; 35: 320-330
3 Barth C, Villringerl A, Sacher J. Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods. Front Neurosci 2015; 9: 37
4 Hoyer J, Burmann I, Kieseler ML. et al. Menstrual cycle phase modulates emotional conflict processing in women with and without premenstrual syndrome (PMS)–a pilot study. PLoS One 2013; 8: e59780
5 Steiner M, Dunn E, Born L. Hormones and mood: From menarche to menopause and beyond. J Affect Disord 2003; 74: 67-83
6 La Marca-Ghaemmaghami P. Gynäkologie und Geburtshilfe. In: Ehlert U. Hrsg. Verhaltensmedizin. Berlin: Springer; 2016: 213-250
7 Graubner B. ICD-10-GM 2006. Systematisches Verzeichnis. Internationale Statistische Klassifikation der Krankheiten und verwandter Gesundheitsprobleme. Köln: Deutscher Ärzteverlag; 2006
8 Martini J, Winkel S, Einsle F. Menstruelle Zyklusstörungen, prämenstruelles Syndrom und prämenstruelle dysphorische Störung. In: Bitzer J, Hoefert HW. Hrsg. Psychologie in der Gynäkologie. Lengerich: Pabst Science Publishers; 2014: 217-239
9 Halbreich U, Backstrom T, Eriksson E. et al. Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies. Gynecol Endocrinol 2007; 23: 123-130
10 Falkai P, Wittchen HU. Diagnostisches und Statistisches Manual Psychischer Störungen: DSM-5. Göttingen: Hogrefe; 2015
11 Payne JL, Palmer JT, Joffe H. A Reproductive subtype of depression: Conceptualizing models and moving toward etiology. Harv Rev Psychiatry 2009; 17: 72-86
12 Soares CN, Zitek B. Reproductive hormone sensitivity and risk for depression across the female life cycle: A continuum of vulnerability?. J Psychiatry Neurosci 2008; 33: 331-343
13 Winkel S, Einsle F, Wittchen HU. et al. Premenstrual symptoms are associated with psychological and physical symptoms in early pregnancy. Arch Womens Ment Health 2013; 16: 109-115
14 Kennerley H, Gath D. Maternity Blues III. Associations with obstetric, psychological, and psychiatric factors. Br J Psychiatry 1989; 155: 367-373
15 Sharma V, Burt VK. DSM-V: Modifying the postpartum-onset specifier to include hypomania. Arch Womens Ment Health 2011; 14: 67-69
16 Stein A, Pearson RM, Goodman SH. et al. Effects of perinatal mental disorders on the fetus and child. Lancet 2014; 384: 1800-1819
17 Beier KM, Wille R, Wessel J. Denial of pregnancy as a reproductive dysfunction: A proposal for international classification systems. J Psychosomat Res 2006; 61: 723-730
18 Hantsoo L, Epperson CN. Premenstrual dysphoric disorder: Epidemiology and treatment. Curr Psychiatry Reports 2015; 17: 87
19 Yonkers KA, McCunn KL. Comorbidity of premenstrual Syndrome and premenstrual dysphoric Disorder with other psychiatric Conditions. In: OʼBrien PMS, Rapkin AJ, Schmidt PJ. eds. The premenstrual Disorders: PMS and PMDD. London: Informa Healthcare; 2007
20 Pearlstein T, Steiner M. Premenstrual dysphoric disorder: burden of illness and treatment update. J Psychiatry Neurosci 2008; 33: 291-301
21 Teatero ML, Mazmanian D, Sharma V. Effects of the menstrual cycle on bipolar disorder. Bipolar Disord 2014; 16: 22-36
22 Martini J, Petzoldt J, Einsle F. et al. Risk factors and course patterns of anxiety and depressive disorders during pregnancy and after delivery: a prospective-longitudinal study. J Affect Disord 2015; 175: 385-395
23 Vesga-López O, Blanco C, Keyes K. et al. Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiatry 2008; 65: 805-815
24 Sharma V, Pope CJ. Pregnancy and bipolar disorder: A systematic review. J Clin Psychiatry 2012; 73: 1447-1455
25 Diflorio A, Jones I. Is sex important? Gender differences in bipolar disorder. Int Rev Psychiatry 2010; 22: 437-452
26 Llaneza P, García-Portilla MP, Llaneza-Suárez D. et al. Depressive disorders and the menopause transition. Maturitas 2012; 71: 120-130
27 Newhouse P, Albert K. Estrogen, stress, and depression A neurocognitive model. JAMA Psychiatry 2015; 72: 727-729
28 Marsh WK, Gershenson B, Rothschild AJ. Symptom severity of bipolar disorder during the menopausal transition. Int J Bipolar Disord 2015; 3: 35
29 Goodman JH, Chenausky KL, Freeman MP. Anxiety disorders during pregnancy: a systematic review. J Clin Psychiatry 2014; 75: e1153-e1184
30 Leach LS, Poyser C, Fairweather-Schmidt K. Maternal perinatal anxiety: A review of prevalence and correlates. Clin Psychologist 2015;
31 Martini J, Asselmann E, Einsle F. et al. A prospective-longitudinal study on the association of anxiety disorders prior to pregnancy and pregnancy- and child-related fears. J Anxiety Disord 2016; 40: 58-66
32 Misri S, Abizadeh J, Sanders S. et al. Perinatal generalized anxiety disorder: Assessment and treatment. J Womens Health 2015; 24: 762-770
33 Martini J, Weidner K, Hoyer J. Angststörungen in der Schwangerschaft und nach der Geburt: Diagnostik und Behandlung. Psychosomatik und Konsiliarpsychiatrie 2008; 4: 207-215
34 Garthus-Niegel S, von Soest T, Vollrath ME. et al. The impact of subjective birth experiences on post-traumatic stress symptoms: a longitudinal study. Arch Womens Ment Health 2013; 16: 1-10
35 Bryant C, Judd FK, Hickey M. Anxiety during the menopausal transition: A systematic review. J Affect Disord 2012; 139: 141-148
36 Bromberger JT, Kravitz HM, Chang Y. et al. Does risk for anxiety increase during the menopausal transition? Study of Womenʼs Health Across the Nation (SWAN). Menopause 2013; 20: 488-495
37 Claudia P, Andrea C, Chiara C. et al. Panic disorder in menopause: A case control study. Maturitas 2004; 48: 147-154
38 Smoller JW, Pollack MH, Wassertheil-Smoller S. et al. Prevalence and correlates of panic attacks in postmenopausal women: Results from an ancillary study to the Womenʼs Health Initiative. Arch Int Med 2003; 163: 2041-2050
39 Maurer K, Häfner H. Die Östrogenhypothese der Schizophrenie – Übersicht und aktueller Stand der Forschung. Journal für Neurologie, Neurochirurgie und Psychiatrie 2002; 3: 26-34
40 Kulkarni J, de Castella A, Fitzgerald PB. et al. Estrogen in severe mental illness: a potential new treatment approach. Arch Gen Psychiatry 2008; 65: 955-960
41 Riecher-Rössler A, Rohde A. Psychische Erkrankungen bei Frauen: Für eine geschlechtersensible Psychiatrie und Psychotherapie. Basel: Karger; 2001
42 Seeman MV. Menstrual exacerbation of schizophrenia symptoms. Acta Psychiatr Scand 2012; 125: 363-371
43 Hallonquist JD, Seeman MV, Lang M. et al. Variation in symptom severity over the menstrual cycle of schizophrenics. Biol Psychiatry 1993; 33: 207-209
44 Jones I, Chandra PS, Dazzan P. et al. Bipolar disorder, affective psychosis, and schizophrenia in pregnancy and the post-partum period. Lancet 2014; 384: 1789-1799
45 Rohde A. Psychiatrische Erkrankungen in der Schwangerschaft und im Wochenbett. Gynäkologe 2001; 4: 315-322
46 Riecher-Rössler A. Psychische Erkrankungen in der Menopause. Depressive Störungen und Psychosen. Gynäkologie 2009; 1: 15-19
47 Riecher-Rössler A, Löffler W, Munk-Joergensen P. What do we really know about late-onset schizophrenia?. Eur Arch Psychiatry Clin Neurosci 1997; 247: 195-208
48 Butera PC. Estradiol and the control of food intake. Physiol Behav 2010; 99: 175-180
49 Attia E, Roberto CA. Should Amenorrhea be a diagnostic criterion for anorexia nervosa?. Int J Eat Disord 2009; 42: 581-589
50 Astrachan-Fletcher E, Veldhuis C, Lively N. et al. The reciprocal effects of eating disorders and the postpartum period: A review of the literature and recommendations for clinical care. J Womens Health 2008; 17: 227-239
51 Torgersen L, Von Holle A, Reichborn-Kjennerud T. et al. Nausea and vomiting of pregnancy in women with bulimia nervosa and eating disorders not otherwise specified. Int J Eating Disord 2008; 41: 722-727
52 Micali N. Eating disorders and pregnancy. Psychiatry 2008; 7: 191-193
53 Lupattelli A, Spigset O, Torgersen L. et al. Medication use before, during, and after pregnancy among women with eating disorders: A study from the Norwegian Mother and Child Cohort Study. PLoS One 2015; 10: e0133045
54 Smink FRE, van Hoeken D, Hoek HW. Epidemiology of eating disorders: incidence, prevalence and mortality rates. Curr Psychiatry Rep 2012; 14: 406-414
55 Baker JH, Runfola CD. Eating disorders in midlife women: A perimenopausal eating disorder. Maturitas 2016; 85: 112-116
56 Jacobi F, Wittchen HU, Hölting C. et al. Prevalence, comorbidity and correlates of mental disorders in the general population: Results from the German Health Interview and Examination Survey (GHS). Psychol Med 2004; 34: 597-611
57 Jacobi F, Höfler M, Strehle J. et al. Psychische Störungen in der Allgemeinbevölkerung: Studie zur Gesundheit Erwachsener in Deutschland und ihr Zusatzmodul Psychische Gesundheit (DEGS1-MH). Nervenarzt 2014; 85: 77-87
58 Escobar JI, Rubio-Stipec M, Canino G. et al. Somatic Symptom Index (SSI) – A new and abridged somatization construct – Prevalence and epidemiological correlates in two large community samples. J Nerv Mental Dis 1989; 177: 140-146
59 Creed F, Barsky A. A systematic review of the epidemiology of somatisation disorder and hypochondriasis. J Psychosom Res 2004; 56: 391-408
60 Hiller W, Rief W, Brähler E. Somatization in the population: from mild bodily misperceptions to disabling symptoms. Soc Psychiatry Psychiatr Epidemiol 2006; 41: 704-712
61 Wittchen H-U, Becker E, Lieb R. et al. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med 2002; 32: 119-132
62 Schmelzer K, Ditzen B, Weise C. et al. Clinical profiles of premenstrual experiences among women having premenstrual syndrome (PMS): Affective changes predominate and relate to social and occupational functioning. Health Care Women Int 2015; 36: 1104-1123
63 Kiesner J, Pastore M. Day-to-day co-variations of psychological and physical symptoms of the menstrual cycle: Insights to individual differences in steroid reactivity. Psychoneuroendocrinology 2010; 35: 350-363
64 Craner JR, Sigmon ST, Young MA. Self-focused attention and symptoms across menstrual cycle phases in women with and without premenstrual disorders. Cognitive Ther Res 2016; 40: 118-127
65 Kamysheva E, Skouteris H, Wertheim EH. et al. A prospective investigation of the relationships among sleep quality, physical symptoms, and depressive symptoms during pregnancy. J Affect Disord 2010; 123: 317-320
66 Nylen KJ, Williamson JA, OʼHara MW. et al. Validity of somatic symptoms as indicators of depression in pregnancy. Arch Womens Ment Health 2013; 16: 203-210
67 Chedraui P, Aguirre W, Hidalgo L. et al. Assessing menopausal symptoms among healthy middle aged women with the Menopause Rating Scale. Maturitas 2007; 57: 271-278
68 Kakkar V, Kaur D, Chopra K. et al. Assessment of the variation in menopausal symptoms with age, education and working/non-working status in north-Indian sub population using menopause rating scale (MRS). Maturitas 2007; 57: 306-314
69 Vanwesenbeeck I, Vennix P, van de Wiel H. ‘Menopausal symptoms’: Associations with menopausal status and psychosocial factors. J Psychosom Obstet Gynecol 2001; 22: 149-158
70 Kraus L, Pabst A, Müller S. 2009 Epidemiological Survey of Substance Abuse in the Adult Population of Hamburg. In: Bühringer G. Hrsg. IFT-Berichte. Bd. 177. München: IFT Institut für Therapieforschung; 2011
71 Prescott E, Osler M, Andersen PK. et al. Mortality in women and men in relation to smoking. Int J Epidemiol 1998; 27: 27-32
72 Carpenter MJ, Saladin ME, Leinbach AS. et al. Menstrual phase effects on smoking cessation: a pilot feasibility study. J Womens Health (Larchmt) 2008; 17: 293-301
73 Witt ED. Puberty, hormones, and sex differences in alcohol abuse and dependence. Neurotoxicol Teratol 2007; 29: 81-95
74 Terner JM, de Wit H. Menstrual cycle phase and responses to drugs of abuse in humans. Drug Alcohol Depend 2006; 84: 1-13
75 Maloney E, Hutchinson D, Burns L. et al. Prevalence and predictors of alcohol use in pregnancy and breastfeeding among Australian women. Birth 2011; 38: 3-9
76 Lange S, Probst C, Quere M. et al. Alcohol use, smoking and their co-occurrence during pregnancy among Canadian women. Addictive Behav 2015; 50: 102-109
77 Connelly CD, Hazen AL, Baker-Ericzen MJ. et al. Is Screening for depression in the perinatal period enough? The co-occurrence of depression, substance abuse, and intimate partner violence in culturally diverse pregnant women. J Womens Health (Larchmt) 2013; 22: 844-852
78 Forray A, Foster D. Substance use in the perinatal period. Curr Psychiatry Rep 2015; 17: 91
79 Rath W, Friese K. Erkrankungen in der Schwangerschaft. Stuttgart: Thieme; 2005
80 BZgA. Stillen und Muttermilchernährung: Grundlagen, Erfahrungen und Empfehlungen. Köln: BZgA; 2001
81 Mikkelsen TF, Graff-Iversen S, Sundby J. et al. Early menopause, association with tobacco smoking, coffee consumption and other lifestyle factors: A cross-sectional study. BMC Public Health 2007; 7: 149
82 Tuchman E. Exploring the prevalence of menopause symptoms in midlife women in methadone maintenance treatment. Soc Work Health Care 2007; 45: 43-62
83 Martini J, Wittchen HU, Soares CN. et al. New women-specific diagnostic modules: the Composite International Diagnostic Interview for Women (CIDI-VENUS). Arch Womens Ment Health 2009; 12: 281-289
84 Bentz D, Steiner M, Meinlschmidt G. SIPS-Screening Instrument for Premenstrual Symptoms. The German version of Premenstrual Symptoms Screening Tool to assess clinically relevant disturbances. Nervenarzt 2012; 83: 33-39
85 Alder J, Fink N, Bitzer J. et al. Depression and anxiety during pregnancy: A risk factor for obstetric, fetal and neonatal outcome? A critical review of the literature. J Matern Fetal Neonatal Med 2007; 20: 189-209
86 Herz E, Thoma M, Umek W. et al. Nicht-psychotische postpartale Depression. Geburtsh Frauenheilk 1997; 57: 282-288
87 Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 1987; 150: 782-786
88 Martini J, Einbock K, Wintermann GB. et al. Die Depression-Angst-Stress-Skala für die Peripartalzeit: Ein Screeninginstrument für die Schwangerschaft und das Wochenbett. Klin Diagn Eval 2009; 42: 288-309
89 Zöllner YF, Acquadro C, Schaefer M. Literature review of instruments to assess health-related quality of life during and after menopause. Qual Life Res 2005; 14: 309-327
90 Heinemann LA, Potthoff P, Schneider HP. International versions of the Menopause Rating Scale (MRS). Health Qual Life Outcomes 2003; 1: 28
91 Kleinstäuber M, Witthöft M, Hiller W. Cognitive-behavioral and pharmacological interventions for premenstrual syndrome or premenstrual dysphoric disorder: A meta-analysis. J Clin Psychol Med Settings 2012; 19: 308-319
92 Adams SS, Eberhard-Gran M, Eskild A. Fear of childbirth and duration of labour: A study of 2206 women with intended vaginal delivery. BJOG 2012; 119: 1238-1246
93 Petzoldt J, Wittchen HU, Einsle F. et al. Maternal anxiety versus depressive disorders: Specific relations to infantsʼ crying, feeding and sleeping problems. Child Care Health Dev 2016; 42: 231-245
94 Mood and anxiety disorders in pregnant and postpartum women. J Obstet Gynecol Neonat Nurs 2015; 44: 687-689
95 Craner JR, Sigmon ST, Young MA. Treatment of anxiety during pregnancy: Room to grow. Cognitive Ther Res 2016; 40: 118-127
96 Hoyer J, Uhmann S, Rambow J. et al. Reduction of sexual dysfunction: A by-product of effective cognitive-behavioural therapy?. Sexual Relationship Ther 2009; 24: 64-73
97 Asselmann E, Hoyer J, Wittchen HU. et al. Sexual problems during pregnancy and after delivery among women with and without anxiety and depressive disorders prior to pregnancy: A prospective-longitudinal study. J Sexual Med 2016; 13: 95-104
98 Ortmann O, Lattrich C. The treatment of climacteric symptoms. Dtsch Arztebl Int 2012; 109: 316-323 quiz 324
99 Stuenkel CA, Davis SR, Gompel A. et al. Treatment of symptoms of the menopause: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2015; 100: 3975-4011
100 Borrelli F, Ernst E. Alternative and complementary therapies for the menopause. Maturitas 2010; 66: 333-343